pmc-enju-pas Home  

PMC:3586680 / 4264-4567 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1490 0-9 NN denotes Integrins
T1491 10-14 VB denotes play
T1492 15-16 DT denotes a
T1493 17-21 NN denotes role
T1494 22-24 IN denotes in
T1495 25-28 DT denotes the
T1496 29-39 NN denotes resistance
T1497 40-42 IN denotes of
T1498 43-51 JJ denotes advanced
T1499 52-59 NN denotes cancers
T1500 60-62 TO denotes to
T1501 63-75 NN denotes radiotherapy
T1502 76-79 CC denotes and
T1503 80-93 NN denotes chemotherapy.
T1504 94-98 NN denotes α5β1
T1505 99-107 NN denotes integrin
T1506 108-118 RB denotes negatively
T1507 119-128 VB denotes regulates
T1508 129-132 NN denotes p53
T1509 133-142 NN denotes signaling
T1510 142-143 -COMMA- denotes ,
T1511 144-147 CC denotes and
T1512 148-151 DT denotes the
T1513 152-157 NN denotes event
T1514 158-165 VB denotes induces
T1515 166-172 NN denotes glioma
T1516 173-177 NN denotes cell
T1517 178-188 NN denotes resistance
T1518 189-191 TO denotes to
T1519 192-195 NN denotes TMZ
T1520 196-197 -LRB- denotes (
T1521 197-207 NNP denotes Janouskova
T1522 208-210 FW denotes et
T1523 211-214 FW denotes al.
T1524 214-215 -COMMA- denotes ,
T1525 216-220 CD denotes 2012
T1526 220-221 -RRB- denotes )
T1527 221-225 CD denotes . α5
T1528 225-233 NN denotes β1 integ
T1529 233-235 VB denotes ri
T1530 235-245 VB denotes n is consi
T1531 245-247 IN denotes de
T1532 247-248 DT denotes r
T1533 248-259 JJ denotes ed as a the
T1534 259-265 NN denotes rapeut
T1535 265-268 IN denotes ic
T1536 268-278 JJ denotes target for
T1537 279-284 NN denotes high-
T1538 284-290 NN denotes grade
R1039 T1490 T1491 arg1Of Integrins,play
R1040 T1491 T1494 arg1Of play,in
R1041 T1491 T1502 arg1Of play,and
R1042 T1493 T1491 arg2Of role,play
R1043 T1493 T1492 arg1Of role,a
R1044 T1496 T1494 arg2Of resistance,in
R1045 T1496 T1495 arg1Of resistance,the
R1046 T1496 T1497 arg1Of resistance,of
R1047 T1496 T1500 arg1Of resistance,to
R1048 T1499 T1497 arg2Of cancers,of
R1049 T1499 T1498 arg1Of cancers,advanced
R1050 T1501 T1500 arg2Of radiotherapy,to
R1051 T1502 T1511 arg1Of and,and
R1052 T1505 T1503 arg1Of integrin,chemotherapy.
R1053 T1505 T1504 arg1Of integrin,α5β1
R1054 T1505 T1507 arg1Of integrin,regulates
R1055 T1507 T1502 arg2Of regulates,and
R1056 T1507 T1506 arg1Of regulates,negatively
R1057 T1509 T1507 arg2Of signaling,regulates
R1058 T1509 T1508 arg1Of signaling,p53
R1059 T1511 T1510 arg1Of and,","
R1060 T1513 T1512 arg1Of event,the
R1061 T1513 T1514 arg1Of event,induces
R1062 T1514 T1511 arg2Of induces,and
R1063 T1517 T1514 arg2Of resistance,induces
R1064 T1517 T1515 arg1Of resistance,glioma
R1065 T1517 T1516 arg1Of resistance,cell
R1066 T1517 T1518 arg1Of resistance,to
R1067 T1519 T1518 arg2Of TMZ,to
R1068 T1519 T1520 arg1Of TMZ,(
R1069 T1519 T1529 modOf TMZ,ri
R1070 T1521 T1520 arg2Of Janouskova,(
R1071 T1521 T1522 arg1Of Janouskova,et
R1072 T1521 T1523 arg1Of Janouskova,al.
R1073 T1521 T1524 arg1Of Janouskova,","
R1074 T1525 T1524 arg2Of 2012,","
R1075 T1526 T1520 arg3Of ),(
R1076 T1528 T1527 arg1Of β1 integ,. α5
R1077 T1528 T1529 arg1Of β1 integ,ri
R1078 T1528 T1530 arg2Of β1 integ,n is consi
R1079 T1530 T1529 arg2Of n is consi,ri
R1080 T1530 T1531 arg1Of n is consi,de
R1081 T1534 T1531 arg2Of rapeut,de
R1082 T1534 T1532 arg1Of rapeut,r
R1083 T1534 T1533 arg1Of rapeut,ed as a the
R1084 T1534 T1535 arg1Of rapeut,ic
R1085 T1538 T1535 arg2Of grade ,ic
R1086 T1538 T1536 arg1Of grade ,target for
R1087 T1538 T1537 arg1Of grade ,high-